💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @WALLSTREETODDS_ | 7 |
| @PolackSki | 6 |
| @FlashAlert_me | 5 |
| @brendan_49 | 5 |
| @BioValues | 4 |
Recent Tweets for GNCA
 |
@suspendedJoey @brendan_49 meaning they should be recognizable. On a side note, that $GNCA concept of "inhibigens" is quite intriguing actually. May 8th 2021, 11:05am |
 |
@WALLSTREETODDS_ $GNCA Out of the 987 other times GNCA was up 2.6% during a trading day, 60% of the time it traded lower by the sam… https://t.co/gjeziZMTT7 May 6th 2021, 9:05am |
|
@WALLSTREETODDS_ $GNCA Out of the 987 other times GNCA was up 2.6% during a trading day, 60% of the time it traded lower by the nex… https://t.co/ythtayJqDL May 6th 2021, 1:05am |
 |
@PolackSki RT @shilric: @PolackSki that was an excellent presentation. They are doing something that few vaccine companies are doing. $GNCA May 5th 2021, 9:05am |
 |
@shilric @PolackSki that was an excellent presentation. They are doing something that few vaccine companies are doing. $GNCA May 4th 2021, 8:05pm |
|
@PolackSki COVID19 T-cell vaccine to be added to Genocea’s pipeline soon. ??? $GNCA #COVID19 https://t.co/Hs436K10Gj May 4th 2021, 8:05pm |
|
@WALLSTREETODDS_ $GNCA Out of the 1375 other times GNCA was up 1.1% during a trading day, 60% of the time it traded lower by the sa… https://t.co/Ox4qCH54bF May 4th 2021, 9:05am |
|
@WALLSTREETODDS_ $GNCA Out of the 560 other times GNCA was up 4.6% during a trading day, 61% of the time it traded lower by the nex… https://t.co/dl23ibjAp5 May 3rd 2021, 11:05pm |
|
@WALLSTREETODDS_ $GNCA Out of the 1175 other times GNCA was up 1.9% during a trading day, 59% of the time it traded lower by the sa… https://t.co/FyBJmdTT9z April 30th 2021, 5:04pm |
|
@PolackSki RT @StuckInStock: $GNCA Liking that GEN-009 platform potential. Updates at ASCO early June 2021. Conference call: https://t.co/l7YudOZMHR… April 30th 2021, 3:04pm |
|
@PolackSki $GNCA $66M cash will last thru 2022. Mixed shelf offering points to significant R&D and clinical trial/pipeline exp… https://t.co/GRYK2YcnHS April 30th 2021, 2:04pm |
 |
@StuckInStock $GNCA Liking that GEN-009 platform potential. Updates at ASCO early June 2021. Conference call:… https://t.co/m5UBWURDlA April 30th 2021, 2:04pm |
|
@WALLSTREETODDS_ $GNCA Out of the 1065 other times GNCA was up 2.3% during a trading day, 57% of the time it traded lower by the ma… https://t.co/uL0nEpbRb8 April 30th 2021, 5:04am |
|
@PolackSki RT @BioValues: $GNCA seems like a possible COVID program update coming on Tuesday at World Vaccine Congress: https://t.co/FbXF5vAc1b April 30th 2021, 12:04am |
 |
@MarcJacksonLA $GNCA Needham Assigns a Buy Rating On Genocea Biosciences, $6 PT https://t.co/srecHpQO4Q April 29th 2021, 11:04pm |
 |
@BioValues $GNCA seems like a possible COVID program update coming on Tuesday at World Vaccine Congress: https://t.co/FbXF5vAc1b April 29th 2021, 9:04pm |
 |
@SiteFocusHQ $GNCA Earnings Intelligence Analysis of recent earnings identified Genocea Biosciences, Inc. (GNCA) business focus… https://t.co/fxRcB2ZzKo April 29th 2021, 9:04pm |
 |
@SeekingAlpha $GNCA - Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q1 2021 Results - Earnings Call Transcript.… https://t.co/pasBxITY8W April 29th 2021, 9:04pm |
 |
@StockNewsNow $GNCA Genocea Provides First Quarter 2021 Corporate Update https://t.co/hROKWtFvyi April 29th 2021, 8:04pm |
 |
@EdgarInsider Filing for 10-Q [Quarterly Report] has been made with the SEC: $GNCA GENOCEA BIOSCIENCES, INC https://t.co/FHLX7NE3qK April 29th 2021, 8:04pm |
 |
@FlashAlert_me $GNCA [15s. delayed] filed form 10-Q on April 29, 16:04:05 https://t.co/WztuXGd1Iz April 29th 2021, 8:04pm |
 |
@sbwcws Genocea files $300M mixed securities shelf $GNCA April 29th 2021, 8:04pm |
|
@FlashAlert_me $GNCA [15s. delayed] filed form S-3 on April 29, 16:02:02 https://t.co/OUgB91FOax April 29th 2021, 8:04pm |
 |
@SmallCapsDaily $GNCA Genocea Provides First Quarter 2021 Corporate Update GlobeNewswire https://t.co/38L1nkjN4T #smallcapsdaily… https://t.co/3uDZvlusfy April 29th 2021, 4:04pm |
|
@MarcJacksonLA $GNCA Genocea Provides First Quarter 2021 Corporate Update https://t.co/dGtaUsk7cD April 29th 2021, 2:04pm |
|
@BioValues Picked up some $GNCA for GEN-009 long-term update at ASCO. Doesn't seem like a bad R/R in mid $2s, and valuation lo… https://t.co/Yvl9zo1sUr April 29th 2021, 2:04pm |
 |
@ba_0830 @jscottart $GNCA keeps beating EPS estimates https://t.co/dcZFbtvFwz April 29th 2021, 1:04pm |
 |
@Gambiste1 RT @jscottart: $GNCA Earnings Growth up 63%. Earnings beats estimates -0.17 vs -0.20 estimate. 15% EPS Surprise. April 29th 2021, 12:04pm |
 |
@jscottart $GNCA Earnings Growth up 63%. Earnings beats estimates -0.17 vs -0.20 estimate. 15% EPS Surprise. April 29th 2021, 12:04pm |
 |
@StockPods $GNCA Earnings Call Today: 8:30 AM EST Webcast: https://t.co/DOAElEZnsj Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 April 29th 2021, 11:04am |
|
@FlashAlert_me $GNCA [15s. delayed] filed form DEFA14A on April 29, 07:16:33 https://t.co/Om5fqlUqqp April 29th 2021, 11:04am |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $GNCA GENOCEA BIOSCIENCES, INC https://t.co/Ncu1blfY2L April 29th 2021, 11:04am |
|
@FlashAlert_me $GNCA [15s. delayed] filed form DEF 14A on April 29, 07:14:24 https://t.co/U2rWPVFJkE April 29th 2021, 11:04am |
 |
@fintel_io $GNCA / Genocea Biosciences files form 8-K - Financial Statements and Exhibits, Results of Operations and Financial… https://t.co/D1FKpgCAfa April 29th 2021, 11:04am |
|
@FlashAlert_me $GNCA [15s. delayed] filed form 8-K on April 29, 07:13:27: Item2.02: Results of Operations & Financial Condition https://t.co/8GDVnXuzlK April 29th 2021, 11:04am |
 |
@otcdynamics $GNCA Genocea Provides First Quarter 2021 Corporate Update https://t.co/JzadkJdPMs April 29th 2021, 11:04am |
 |
@StckPro $GNCA NEW ARTICLE : Genocea Provides First Quarter 2021 Corporate Update https://t.co/sYXOONtASP Get all the latest… https://t.co/9Q6ul29iUF April 29th 2021, 11:04am |
|
@sbwcws Genocea expects cash to fund operations to the end of 2022 $GNCA April 29th 2021, 11:04am |
 |
@kevinjaybe $GNCA Genocea Provides First Quarter 2021 Corporate Update https://t.co/HmKBpmiOsv April 29th 2021, 11:04am |
 |
@stock_titan $GNCA Genocea Provides First Quarter 2021 Corporate Update https://t.co/xK7c1367iT April 29th 2021, 11:04am |
 |
@AccesswireNews $GNCA Genocea Biosciences, Inc. to Host Earnings Call https://t.co/AlaaWoUGP2 April 29th 2021, 10:04am |
|
@BioValues @bio_report @PropThinker Yeah I remember that. $GNCA EV only $60M, so doesn't seem like a bad bet though April 28th 2021, 9:04pm |
|
@BioValues @PropThinker $GNCA seems to hint what is to come at ASCO? https://t.co/aGDrH9qd98 April 28th 2021, 9:04pm |
 |
@SelfThink4 RT @SelfThink4: $MRKR lots of encouraging insider buys after the recent offering. Good risk/reward imho. $GNCA ? April 28th 2021, 8:04pm |
 |
@PropThinker $GNCA #ASCO21 abstract Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, comb… https://t.co/C9TRtbAdYs April 28th 2021, 7:04pm |
 |
@kwhenfinance Genocea Biosciences Inc Shares Close the Week 27.6% Higher - Weekly Wrap https://t.co/RhgJfrQGSd $GNCA #stockmarket #kwhenfinance April 27th 2021, 12:04am |
|
@Gambiste1 RT @brendan_49: @AaronRosenblum5 Who is $GNCA working w/ for their cell therapy? All these other platforms emerged out of non-profit sett… April 26th 2021, 3:04pm |
 |
@brendan_49 @AaronRosenblum5 I’ll leave it like this: I think $GNCA has a small, maybe tiny, but better chance than TCR-T playe… https://t.co/4kmCtcXtQR April 26th 2021, 3:04pm |
|
@PolackSki RT @AaronRosenblum5: @brendan_49 I think the problem is anyone else attempting that is likely to violate $gnca ip. I’m surprised they aren’… April 26th 2021, 3:04pm |
|
@brendan_49 @AaronRosenblum5 Who is $GNCA working w/ for their cell therapy? All these other platforms emerged out of non-pro… https://t.co/Pi8kw2r4MO April 26th 2021, 3:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
